Abstract
The most important factors for development of cardiovascular disease are increasing age, male gender, lipoprotein disturbances, arterial hypertension and smoking. Premenopausal women have a more advantageous pattern of serum lipoproteins than males and there is a considerably lower frequency of cardiovascular disease in females than in males of comparable ages. The variation in lipoprotein distribution between genders is mainly due to their different production of sex steroids.
This review is based on the paper (in Swedish) ‘Sexualsteroider och lipoproteiner’ by Lars Wallentin, that was read at the symposium ‘Klimakteriet och dess behandling’ in Linköping, Sweden, on September 9, 1982
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Levy, R. I. (1981). Cholesterol, lipoproteins, apoproteins and heart disease: Present status and future prospects. Clin. Chem., 27, 653
Wallentin, L. and Larsson-Cohn, U. (1977). Metabolic and hormonal effects of postmenopausal estrogen replacement treatment. II. Plasma lipids. Acta Endocrinol., 86, 597
Fåhraeus, L., Larsson-Cohn, U. and Wallentin, L. (1982). Lipoproteins during oral and cutaneous administration of oestradiol-17β to menopausal women. Acta Endocrinol., 101, 597
FÃ¥hraeus, L., Laesson-Cohn, U. and Wallentin, L. L-Norgestrel and progesterone have different influences on plasma lipoproteins. Eur. J. Clin. Invest (In press)
FÃ¥hraeus, L., Larsson-Cohn, U. and Wallentin, L. (1984). Rapid and reversible alterations of LDL, HDL, HDL2 and HDL3 during and after danazol treatment. Fertil. Steril. (In press)
Larsson-Cohn, U., FÃ¥hraeus, L., Wallentin, L. and Zador, G. (1981). Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil. Steril., 35, 172
Wallentin, L. and Varenhorst, E. (1981). Plasma lipoproteins during antiandrogen treatment by estrogens or orchidectomy in men with protastic carcinoma. Horm. Metab. Res., 13, 293
Fåhraeus, L., Larsson-Cohn, U. and Wallentin, L. Pronounced elevations of HDL2, LDL and VLDL in human pregnancy — results from the first truly prospective study. (Submitted for publication)
Hirvonen,E., Mälkönen, M. and Manninen, V. (1981). Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N. Engl. J. Med., 304, 560
Tikkanen, M. J., Nikkilä, E. A. and Vartiainen, E. (1978). Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women. Lancet, 2, 490
Heiss, G., Tamir, I., Davis, C. E., Tyroler, H. A., Rifkind, B. M., Schonfeld, G., Jacobs, D. and Frantz, I. D. (1980). Lipoprotein — cholesterol distributions in selected North-American populations: The lipid research clinics program prevalence study. Circulation, 61, 302
Mendoza, S. G., Osuna,A., Zerpa, A., Gartside, P. S. and Glueck, C. J. (1981). Hypertriglyceridemia and hypoalphalipoproteinemia in azoospermic and oligospermic young men: Relationships of endogenous testosterone to triglyceride and high density lipoprotein cholesterol metabolism. Metabolism, 30, 481
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 MTP Press Limited
About this chapter
Cite this chapter
Larsson-Cohn, U., Wallentin, L. (1984). Sex steroids and lipoproteins. In: van Herendael, H., van Herendael, B., Riphagen, F.E., Goessens, L., van der Pas, H. (eds) The Climacteric: An Update. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5608-7_8
Download citation
DOI: https://doi.org/10.1007/978-94-009-5608-7_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8973-9
Online ISBN: 978-94-009-5608-7
eBook Packages: Springer Book Archive